Microbiology testing and diagnostics firm PathoQuest today announced the closing of an €8 million ($8.9 million) financing round.

Quidel reported after the close of the market Thursday that its second quarter revenues rose 5 percent year over year due primarily to growth in the firm's rapid immunoassay business.

Bio-Rad Laboratories reported after the close of the market Thursday that its second quarter revenues decreased approximately 1 percent year over year.

Coriell Life Sciences and global professional services firm KPMG said today that they have entered into a partnership with to provide pharmacogenomics data to clinicians at the point of care.

Genomenon has entered the Chinese market by forming a partnership with Shanghai Shanyi Biological Technology Co., a provider of sequencing interpretation, variant validation, and other molecular technology services.

Expedeon reported today an 18 percent increase in second quarter revenues driven in part by sales generated by recently acquired reagent maker TGR Biosciences.

Bio-Techne said today that its fiscal 2019 fourth quarter revenues rose 6 percent over fiscal Q4 2018.

Becton Dickinson reported a 2 percent year-over-year increase in its fiscal third quarter revenues today.

Aqualung Therapeutics said on Tuesday that it has been awarded a $225,000 grant from the National Institutes of Health to develop a panel of biomarkers, called CRIT-ICU, for stratifying patients at risk for acute respiratory distress syndrome (ARDS).

Cancer Genetics today reported a 15 percent increase in second quarter revenues on improved performance by its core discovery services operations.

Biotechnology company Freenome and ADC Therapeutics, an oncology drug discovery and development company, announced today that they have signed a biomarker development agreement.

Genomenon has entered the Chinese market by forming a partnership with Shanghai Shanyi Biological Technology Co., a provider of sequencing interpretation, variant validation, and other molecular technology services.

The FDA has cleared Drawbridge Health¡¯s blood collection device designed to help monitor long-term blood sugar levels in people with diabetes, which the company describes as easier and less painful than a hypodermic needle.

Abbott Laboratories could have the golden touch when it comes down to detecting traumatic brain injuries (TBI).

Abbott Laboratories has developed a portable tool to help law enforcement agencies crack down on people driving under the influence. The Abbott Park, IL-based company looks to expand the reach of the diagnostic tool ¨C S..